welcome
Investor's Business Daily

Investor's Business Daily

Health

Health

Novo Pops After Ozempic Beats. But Supply Shortages Expected.

Investor's Business Daily
Summary
Nutrition label

83% Informative

Weight-loss drug maker Novo Nordisk reports fourth-quarter sales of $11.92 billion .

Wegovy, Ozempic and Ozemp generate $2.77 billion in sales.

For the year , Novo expects 16% to 24% sales growth excluding the impact of exchange rates.

VR Score

86

Informative language

87

Neutral language

55

Article tone

formal

Language

English

Language complexity

32

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

Affiliate links

no affiliate links